Scientists launch major study to unravel rare genetic disorder
NCT ID NCT05374616
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to collect medical information and biological samples from 300 people with TANGO2-related disorder, a rare genetic condition. By tracking health events like metabolic and cardiac crises over time, researchers hope to better understand the disease course. The goal is to build a comprehensive database and biorepository to support future research and potential treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study will provide crucial insights into TANGO2 deficiency, potentially guiding future treatments and improving care for affected individuals.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants and may take years to yield meaningful results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TANGO2-RELATED DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Baylor College of Medicine
RECRUITINGHouston, Texas, 77030, United States